The clinical epidemiology of fatigue in newly diagnosed heart failure

Table 3 Medications of newly diagnosed heart failure patients stratified by fatigue status at baseline

	All patients (n = 12,285)	No Fatigue (n = 7458)	Fatigue (n = 4827)	p-value
ACE inhibitor, %	68	67	68	0.34
Angiotensin receptor blocker, %	21	19	24	<0.001
Antiarrhythmic type III, %	19	18	21	<0.001
Anticoagulants, %	38	36	40	<0.001
Antiplatelet, %	27	25	29	<0.001
Aspirin, %	76	74	79	<0.001
Beta blocker, %	80	78	82	<0.001
Calcium channel blocker, %	45	43	49	<0.001
Digoxin, %	19	19	19	0.61
Diuretic, %	88	86	90	<0.001
Nitrates, %	47	45	50	<0.001
Statin, %	66	65	68	<0.001
Antidepressant, %	41	34	54	<0.001

ISSN: 1471-2261